Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Two independent consecutive lymphoma cases carry an identical MYD88 mutation but differ in their IGVH rearrangement.

British journal of haematology - 1 Sept 2020

Prieto-Torres Lucía, Trascasa Álvaro, Manso Rebeca, Machan Salma, Cieza-Diaz Deisy, Olmedilla Gabriel, García-García Mar, Ara-Martín Mariano, Requena Luis, Piris Miguel Á, Rodríguez-Pinilla Socorro M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclophosphamide
Share to Doxorubicin
Share to Gene Rearrangement, B-Lymphocyte, Heavy Chain

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, Large B-Cell, Diffuse

Share to Myeloid Differentiation Factor 88

Share to Prednisone

Share to Rituximab

Share to Vincristine

Source

Identifiers

PMID: 32578872
DOI: 10.1111/bjh.16917

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Two independent consecutive lymphoma cases carry an identical MYD88 mutation but differ in their IGVH rearrangement.PMID 32578872Read ↗

Oncogenic MYD88 mutations are rare events in double-hit B-cell lymphomas.Semantic proximity Read ↗

MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell LymphomaSemantic proximity Read ↗

Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL.Semantic proximity Read ↗

Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical PracticeSemantic proximity Read ↗

MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphomaSemantic proximity Read ↗

MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications.Semantic proximity Read ↗

MYD88 Somatic Mutation Is a Genetic Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg TypeSemantic proximity Read ↗

Detection of MYD88 Mutations in Vitreoretinal Lymphoma and Its Implications.Semantic proximity Read ↗

Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.Semantic proximity Read ↗

MYD88 gene and protein: molecular architecture, signalling mechanisms and clinical implications in lymphoid malignancies.Semantic proximity Read ↗

Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features.Semantic proximity Read ↗

[Detection of MYD88 mutation in lymphoma by PCR-high resolution melting curve analysis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.